vimarsana.com
Home
Live Updates
Nouscom Announces New Translational Phase 1 Data of NOUS-209
Nouscom Announces New Translational Phase 1 Data of NOUS-209
Nouscom Announces New Translational Phase 1 Data of NOUS-209, an 'off-the-shelf' Neoantigen Cancer Vaccine for the Treatment of MSI-H Solid Tumors, at AACR 2022
/PRNewswire/ -- Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized viral vectored immunotherapies, today announced...
Related Keywords
Italy ,
Ankara ,
Turkey ,
United States ,
Rome ,
Lazio ,
Switzerland ,
American ,
Eleanor Perkin ,
Prnewswire Nouscom ,
Rick Davis ,
Marwang Fakih ,
Sylvie Berrebi ,
Elisa Scarselli ,
American Association For Cancer Research ,
Linkedin ,
Society For Immunotherapy Of Cancer ,
Late Breaking ,
Cancer Research ,
Microsatellite Instable High ,
Annual Meeting ,
Medical Oncology Specialist ,
Duarte California ,
Chief Scientific Officer ,
Presentation Details ,
Microsatellite Instability ,
Great Ape Adenoviral ,
Modified Vaccinia Ankara ,
Nouscom ,